Daniel Egetemeyr

Statistics

Publications

Citations

170

H-Index

Active since

2012

Affiliations

University Children's Hospital Tübingen(Current)

University of Tübingen

Daniel Egetemeyr is an author at University Children's Hospital Tübingen specializing in interferon-based therapy, infectious diseases, and antiviral therapy.

Publications per year

2012–2016

Publications

Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: A 12-week pilot study providing safety and efficacy data

Christoph R. Werner, Daniel Egetemeyr, Ulrich M. Lauer et al. · Liver Transplantation · 2012 · 74 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12

Christoph R. Werner, Julia Schwarz, Daniel Egetemeyr et al. · World Journal of Gastroenterology · 2016 · 55 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Treatment of Recurrent Genotype 1 Hepatitis C Post-Liver Transplantation: Single Center Experience with Telaprevir-Based Triple Therapy

Christoph R. Werner, Daniel Egetemeyr, Silvio Nadalin et al. · Zeitschrift für Gastroenterologie · 2014 · 17 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohort

Christoph R. Werner, C. Franz, Daniel Egetemeyr et al. · Virology Journal · 2015 · 13 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Feasibility of Telaprevir-Based Triple Therapy in Liver Transplant Patients with Hepatitis C Virus: SVR 24 Results

Christoph R. Werner, Daniel Egetemeyr, Ulrich M. Lauer et al. · PLoS ONE · 2013 · 11 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

1–5 of 5